1Zykowska J, Kurzyna M, Pietura R, et al. Recurrent hemoptysis : an emerging life-threatening complication in idiopathic pulmonary arterial hypertension. Chest ,2011,139 ( 3 ) :690-693.
2Jason M, Samuelian Albert A, Attia Courtney A, et al. Treatment of hemoptysis associated with aspergilloma using external beam radiotherapy:A case report and literature review. Practical Radia- tion Oncology ,2011,1 (4) :279-281.
3Soares Pires F,Teixeira N, Coelho F, et al. Hemoptysis-etiology, evaluation and treatment in a university hospital. Rev Port Pneu- mol,2011,17( 1 ) :7-14.
4Baltaciolu F, Cimit NC, Bostanci K, et al. Transarterial microcath- eter glue embolization of the bronchial artery for life-threatening hemoptysis : technical and clinical results. Eur J Radiol, 2010,73 (2) :380-384.
7Bunnett NW. Protease-activated receptors:how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost, 2006,32 ( Suppl 1 ) :39-48.
9Konings J, Govers-Riemslag JW,PhiLippou H, et al. Actor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood ,2011,118 (14) :3942-3951.
8WeiWL SunJJ ChenJS.Synergism of procoagulation effect of thrombin-like enzymes from Dienagkistrodon acutus and Agkistrodon halys snake venoms[J].中国药理学报,1996,17:527-531.
9Salazar AM, Rodriguez-Acosta A, Giron ME, et al. A comparative analysis of the clotting and frbrinolytic activities of the snake venom ( Bothrops atrox) from different geographical areas in Venezuela. Thromb Res ,2007 ; 120:95 - 104
